BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38764809)

  • 21. Fate of Surgical Patients with Small Nonfunctioning Pancreatic Neuroendocrine Tumors: An International Study Using Multi-Institutional Registries.
    Han IW; Park J; Park EY; Yoon SJ; Jin G; Hwang DW; Jiang K; Kwon W; Xu X; Heo JS; Fu DL; Lee WJ; Bai X; Yoon YS; Yang YM; Ahn KS; Yuan C; Lee HK; Sun B; Park EK; Lee SE; Kang S; Lou W; Park SJ
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).
    Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG
    Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
    Kuo EJ; Salem RR
    Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors.
    Yang B; Chen HY; Zhang XY; Pan Y; Lu YF; Yu RS
    Eur J Radiol; 2020 Mar; 124():108847. PubMed ID: 31991300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
    Assi HA; Mukherjee S; Kunz PL; Machiorlatti M; Vesely S; Pareek V; Hatoum H
    Oncologist; 2020 Feb; 25(2):e276-e283. PubMed ID: 32043766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors for Recurrence in Pancreatic Neuroendocrine Tumor and Size as a Surrogate in Determining the Treatment Strategy: A Korean Nationwide Study.
    Kwon W; Jang JY; Song KB; Hwang DW; Kim SC; Heo JS; Choi DW; Hwang HK; Kang CM; Yoon YS; Han HS; Park JS; Hong TH; Cho CK; Ahn KS; Lee H; Lee SE; Jeong CY; Roh YH; Kim HJ;
    Neuroendocrinology; 2021; 111(8):794-804. PubMed ID: 33002889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.
    Sun Y; Wang Y; Li R; Kang G; Zhang M; Chen X; Jin M; Liu Y; He Y; Zhu X; Kang Q; Zhou F; Yu Q
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101432. PubMed ID: 32386797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors.
    Furukori M; Imai K; Karasaki H; Watanabe K; Oikawa K; Miyokawa N; Taniguchi M; Furukawa H
    World J Gastroenterol; 2014 Dec; 20(47):17949-54. PubMed ID: 25548493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reappraisal of a 2-cm Cutoff Size for the Management of Nonfunctional Pancreatic Neuroendocrine Tumors: A Population-Based Study.
    Yang Z; Zhang D; Shi G
    Front Endocrinol (Lausanne); 2022; 13():928341. PubMed ID: 35923628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
    Fernández-Cruz L; Blanco L; Cosa R; Rendón H
    World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-trend and recurrence analysis of pancreatic neuroendocrine tumors.
    Kim H; Song KB; Hwang DW; Lee JH; Alshammary S; Kim SC
    Endocr Connect; 2019 Jul; 8(7):1052-1060. PubMed ID: 31252400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors.
    Zhou B; Fang B; Yan S; Wang W
    Clin Lab; 2017 Jul; 63(7):1251-1259. PubMed ID: 28792692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors.
    Gaujoux S; Partelli S; Maire F; D'Onofrio M; Larroque B; Tamburrino D; Sauvanet A; Falconi M; Ruszniewski P
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4784-9. PubMed ID: 24057286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Surgery for Pancreatic Neuroendocrine Tumors.
    Ziogas IA; Schmitz R; Moris D; Vatsaas CJ
    Anticancer Res; 2022 Feb; 42(2):629-639. PubMed ID: 35093860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
    Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of systemic immune-inflammation index in patients with nonfunction pancreatic neuroendocrine tumor undergoing surgical resection.
    Chen G; Liu L; Tan C; Tan Q; Chen Y; An X; Liu X; Wang X
    Cancer Med; 2024 Apr; 13(7):e7114. PubMed ID: 38553949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Zhang IY; Zhao J; Fernandez-Del Castillo C; Braun Y; Razmdjou S; Warshaw AL; Lillemoe KD; Ferrone CR
    J Gastrointest Surg; 2016 Feb; 20(2):277-83. PubMed ID: 26691146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic Duct Involvement in Well-Differentiated Neuroendocrine Tumors is an Independent Poor Prognostic Factor.
    Nanno Y; Matsumoto I; Zen Y; Otani K; Uemura J; Toyama H; Asari S; Goto T; Ajiki T; Okano K; Suzuki Y; Takeyama Y; Fukumoto T; Ku Y
    Ann Surg Oncol; 2017 Apr; 24(4):1127-1133. PubMed ID: 27822631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphovascular Invasion Predicts Lymph Node Involvement in Small Pancreatic Neuroendocrine Tumors.
    Blakely AM; Lafaro KJ; Li D; Kessler J; Chang S; Ituarte PHG; Lee B; Singh G
    Neuroendocrinology; 2020; 110(5):384-392. PubMed ID: 31401633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Prognostic Scoring System for the Prediction of Metastatic Recurrence Following Curative Resection of Pancreatic Neuroendocrine Tumors.
    Sho S; Court CM; Winograd P; Toste PA; Pisegna JR; Lewis M; Donahue TR; Hines OJ; Reber HA; Dawson DW; Tomlinson JS
    J Gastrointest Surg; 2019 Jul; 23(7):1392-1400. PubMed ID: 30353489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.